The new factory measures 170,000 square meters and aims to increase production of the slimming products Ozempic and Wegovy. Demand for the medicines has increased enormously in recent months. As a result, there is a major shortage of the drug in several European countries, including Belgium. This is especially a problem for diabetes patients, for whom the medicine is actually intended.
In Belgium, the medicines agency FAGG recently called on doctors to only prescribe Ozempic to diabetics and people with severe obesity for the time being.
LOOK. Our journalist buys Ozempic on the black market
Novo Nordisk CEO Lars Fruergaard Jorgensen previously said that the company will not be able to meet the massive demand “in the near future”. For that reason he now wants to increase production. Thanks to the Ozempic hype, Novo Nordisk became the most valuable company in Europe last month.
2023-11-10 16:08:02
#Ozempic #maker #allocating #billions #increase #production #waste #material
